Back to today’s briefing

Story perspectives

Immunotherapy Sparks Hope: One-Third of Myeloma Patients Cured

6/4/2025

31 7

Summary

Story summary

In a groundbreaking study of 97 patients battling incurable multiple myeloma, immunotherapy from Legend Biotech has sparked hope. Astonishingly, one-third achieved complete remission, remaining cancer-free after five years. This remarkable success has led American oncologists to consider the potential for a cure, transforming the narrative around this once-dismal diagnosis.

1 of 1

Story summary

In a groundbreaking study of 97 patients battling incurable multiple myeloma, immunotherapy from Legend Biotech has sparked hope. Astonishingly, one-third achieved complete remission, remaining cancer-free after five years. This remarkable success has led American oncologists to consider the potential for a cure, transforming the narrative around this once-dismal diagnosis.